Clinical Research Division, Fred Hutch
Dr. Jordan Gauthier is developing and improving cellular immunotherapies for people with blood cancers like leukemia and lymphoma. These therapies include blood stem cell transplantation and a genetically modified immune cell therapy called chimeric antigen receptor T-cell therapy (or CAR T-cell therapy). In addition to designing and conducting clinical trials, Dr. Gauthier builds innovative statistical and machine-learning models to predict patient outcomes on these therapies. Web applications and other new tools he develops will help doctors and patients understand and predict how well cellular therapy will work for them. Dr. Gauthier is also a hematologist-oncologist who cares for patients with blood cancers, especially those undergoing transplant or immunotherapy.
University of Washington
Seattle Cancer Care Alliance
Immunotherapy Integrated Research Center Research Fellow, Fred Hutch, Seattle, 2017-2019
Specialty diploma in Clinical Hematology; Lille Faculty of Medicine, Lille, France, 2015
Doctorate of Medicine; summa cum laude with distinction; Henri Warembourg Faculty of Medicine, Lille, France, 2014
M.Sc. cum laude; Lille Faculty of Medicine, Lille, France, 2012 Residency and Clinical Hematology Fellowship; Lille Faculty of Medicine, Lille, France, 2008-2015
M.D. (graduate diploma of basic medical training); Rennes Faculty of Medicine, Rennes, France, 2008
Bone Marrow Transplantation
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210.